Abstract | OBJECTIVES: BACKGROUND: METHODS: C57BL/6J mice were exposed to chronic intermittent hypoxia (CIH) for 6 weeks (5 days/week, 8 h/day, alternating cycles of hypoxia and normoxia, each lasting 120 s, nadir FiO2: 7%). Blood pressure was monitored by telemetric catheters implanted into the abdominal aorta. Pharmacological inhibition of NOX by apocynin and NOX2-deficient mice were used to assess the role of NOX in CIH-induced arterial hypertension. NOX2 gene expression was measured by real-time PCR in different cardiovascular tissues. RESULTS: When compared with room air conditions, wild-type mice showed significant blood pressure elevations after exposure to CIH. This response was attenuated after treating animals with apocynin and in NOX2 (=gp91) knockout mice, whereas NOX2 was not upregulated in the heart, aorta, and femoral/carotid arteries of CIH mice. CONCLUSION: We suggest that the CIH-induced arterial hypertension is mediated by ROS derived from an activation of NOX2 within cells located outside the cardiovascular system.
|
Authors | Richard Schulz, Gulsina Murzabekova, Bakytbek Egemnazarov, Simone Kraut, Hans-Joachim Eisele, Rio Dumitrascu, Jörg Heitmann, Michael Seimetz, Martin Witzenrath, Hossein A Ghofrani, Ralph T Schermuly, Friedrich Grimminger, Werner Seeger, Norbert Weissmann |
Journal | Journal of hypertension
(J Hypertens)
Vol. 32
Issue 2
Pg. 300-5
(Feb 2014)
ISSN: 1473-5598 [Electronic] Netherlands |
PMID | 24270180
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetophenones
- Enzyme Inhibitors
- Membrane Glycoproteins
- RNA, Messenger
- Reactive Oxygen Species
- acetovanillone
- Cybb protein, mouse
- NADPH Oxidase 2
- NADPH Oxidases
|
Topics |
- Acetophenones
(pharmacology)
- Animals
- Blood Pressure
(physiology)
- Disease Models, Animal
- Enzyme Inhibitors
(pharmacology)
- Hypertension
(enzymology, etiology, physiopathology)
- Male
- Membrane Glycoproteins
(antagonists & inhibitors, genetics, physiology)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- NADPH Oxidase 2
- NADPH Oxidases
(antagonists & inhibitors, genetics, physiology)
- Oxidative Stress
- RNA, Messenger
(genetics, metabolism)
- Reactive Oxygen Species
(metabolism)
- Risk Factors
- Sleep Apnea, Obstructive
(complications, enzymology)
|